166 related articles for article (PubMed ID: 15595689)
21. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].
Pushkar' DIu; Rasner PI; Skobelev PP
Urologiia; 2001; (6):48-54. PubMed ID: 11785083
[No Abstract] [Full Text] [Related]
22. [Clinical studies of transurethral resection in patients with benign prostatic hypertrophy].
Nakajima H; Mori K; Ohnishi S; Kato S; Tanda H
Hinyokika Kiyo; 1988 Aug; 34(8):1411-4. PubMed ID: 2461645
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy.
Ellinger J; Müller SC; Wernert N; von Ruecker A; Bastian PJ
BJU Int; 2008 Aug; 102(5):628-32. PubMed ID: 18410441
[TBL] [Abstract][Full Text] [Related]
24. [Early diagnosis of cancer of the prostate. Value of systemic screening and of diagnosis in incidental cancer (stage A)].
Solé Balcells FJ
Arch Esp Urol; 1989; 42 Suppl 2():131-8. PubMed ID: 2484149
[TBL] [Abstract][Full Text] [Related]
25. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.
Palisaar JR; Wenske S; Sommerer F; Hinkel A; Noldus J
BJU Int; 2009 Sep; 104(5):611-5. PubMed ID: 19298408
[TBL] [Abstract][Full Text] [Related]
26. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
27. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b.
Masue N; Deguchi T; Nakano M; Ehara H; Uno H; Takahashi Y
Int J Urol; 2005 Dec; 12(12):1045-9. PubMed ID: 16409608
[TBL] [Abstract][Full Text] [Related]
28. [Combined use of TUVP and TURP for prostate cancer with bladder outlet obstruction].
Yang GT; Yao MY; Yang JJ; Yuan Z; Liu J; Huo MD; Zhang XW
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):523-5. PubMed ID: 16078672
[TBL] [Abstract][Full Text] [Related]
29. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement.
Bhuiyan AK; Kibria SA; Subhan SS
Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):51-9. PubMed ID: 15813483
[TBL] [Abstract][Full Text] [Related]
30. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
Ploussard G; Dubosq F; Boublil V; Allory Y; de la Taille A; Vordos D; Hoznek A; Abbou CC; Salomon L
J Urol; 2009 Oct; 182(4):1342-9. PubMed ID: 19683310
[TBL] [Abstract][Full Text] [Related]
31. Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time.
Bott SR; Freeman AA; Stenning S; Cohen J; Parkinson MC
BJU Int; 2005 Jan; 95(1):34-9. PubMed ID: 15638892
[TBL] [Abstract][Full Text] [Related]
32. [Prostatic cancer after transurethral resection for benign prostatic hypertrophy].
Fukuoka H; Takeda M; Nomura S; Shiba T; Sakanishi S
Hinyokika Kiyo; 1992 Aug; 38(8):903-6. PubMed ID: 1384292
[TBL] [Abstract][Full Text] [Related]
33. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
34. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM; Hong JH; Choi HY
Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
[TBL] [Abstract][Full Text] [Related]
35. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
[TBL] [Abstract][Full Text] [Related]
36. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
[TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
38. [Transurethral prostatectomy with the bipolar plasma kinetic technique for benign prostate hyperplasia: a report of 297 cases].
Song XS; Che XY; Wang JB; He ZZ; Jiang T; Yin JB; Zhang RK
Zhonghua Nan Ke Xue; 2005 Feb; 11(2):140-1, 144. PubMed ID: 15755037
[TBL] [Abstract][Full Text] [Related]
39. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
Khatami A; Hugosson J; Wang W; Damber JE
Scand J Urol Nephrol; 2009; 43(1):12-8. PubMed ID: 18949633
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens.
Winkler MH; Livni N; Mannion EM; Hrouda D; Christmas T
BJU Int; 2007 Mar; 99(3):554-8. PubMed ID: 17407514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
